MedDataX Logo

Marijuana for Cancer Pain

NCT ID: NCT00046709

Last Updated: 2013-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-09-30

Study Completion Date

2004-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include nausea and/or vomiting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To take part in this study, you must have ongoing cancer pain which is currently being treated with opioids. If you meet all the eligibility criteria you will be admitted to the General Clinical Research Center at San Francisco General Hospital for 9 days. The treatment consists of smoking one marijuana cigarette 3 times a day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cancer pain All types of cancer except lung cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smoked Marijuana

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have ongoing cancer pain
* Be diagnosed with cancer and have at least a six month survival.
* Be on a stable dose of opioid medication for at least 2 weeks before enrollment.
* Have smoked marijuana on at least 6 occasions in their lifetime prior to enrollment.

Exclusion Criteria

You must not:

* Start chemotherapy, radiation or biphosphonates during the study, or have received any new intervention with any such agents within the past 4 weeks.
* Currently be using smoked tobacco products.
* Currently be in methadone treatment.
* Have smoked marijuana within 30 days of enrollment.
* Be diagnosed with diabetes mellitus.
* Have severe heart disease, uncontrolled hypertension, or lung disease.
* Currently be receiving treatment with corticosteroids.
* Be pregnant or breastfeeding.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, San Francisco

OTHER

Sponsor Role collaborator

Center for Medicinal Cannabis Research

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Donald I Abrams, M.D.

Role: PRINCIPAL_INVESTIGATOR

UCSF Community Consortium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, San Francisco

San Francisco, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://cmcr.ucsd.edu

Center for Medicinal Cannabis Research

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CC#057

Identifier Type: -

Identifier Source: secondary_id

C00-SF-108

Identifier Type: -

Identifier Source: org_study_id

NCT00052871

Identifier Type: -

Identifier Source: nct_alias